Mediterranean diet linked to lower risk of obesity-related cancers

Publicly released:
International
Photo by Jasmin Schreiber on Unsplash
Photo by Jasmin Schreiber on Unsplash

People who adhere more strongly to a Mediterranean diet are at a slightly lower risk of developing cancers known to be linked to obesity, according to international researchers who say this link is not fully explained by body weight. A Mediterranean diet high in whole grains, fruits, vegetables and healthy fats has been linked to a lower cancer risk before, so the researchers analysed diet and health data from over 450,000 Europeans, 4.9% of whom developed a cancer considered obesity-related during the study. The researchers say those whose diet most closely resembled the Mediterranean diet had a 6% lower risk of developing an obesity-related cancer compared to those whose diet was the least similar, and even a medium adherence to the diet was linked to a reduced risk. Looking at measurements of obesity, the researchers say the participants' BMIs and waist to hip ratios did not explain this reduced risk, which means a lower cancer risk may not just be related to having a lower weight.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: University of Navarra, Spain
Funder: This study was supported by grant FI19/00236 from the Instituto de Salud Carlos III (Dr Aguilera-Buenosvinos) and PhD studentship in Molecular, Genetic and Lifecourse Epidemiology grant 224982/Z/ 22/Z from theWellcome Trust (Ms Morales Berstein). The coordination of the European Prospective Investigation Into Cancer and Nutrition (EPIC) study is financially supported by the International Agency for Research on Cancer (IARC) and the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, which has additional infrastructure support provided by the National Institute for Health Research Imperial Biomedical Research Centre. The national cohorts are supported by the Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale, and Institut National de la Santé et de la Recherche Médicale (France); German Cancer Aid, German Cancer Research Centre, German Institute of Human Nutrition Potsdam-Rehbruecke, and Federal Ministry of Education and Research (Germany); Associazione Italiana per la Ricerca sul Cancro, Compagnia di SanPaolo, and National Research Council (Italy); Dutch Ministry of Public Health,Welfare and Sports, Netherlands Cancer Registry, LK Research Funds, Dutch Prevention Funds, Zorg Onderzoek Nederland,World Cancer Research Fund, and Statistics Netherlands (the Netherlands); Health Research Fund–Instituto de Salud Carlos III, regional governments of Andalucía, Asturias, Basque Country, Murcia, and Navarra, and the Catalan Institute of Oncology (Spain); Swedish Cancer Society, Swedish Research Council, and County Councils of Skåne and Västerbotten (Sweden); grants 14136 to EPIC-Norfolk and C8221/A29017 to EPIC-Oxford from Cancer Research UK, and grants 1000143 to EPIC-Norfolk and MR/M012190/1 to EPIC-Oxford from the Medical Research Council (UK).
Media Contact/s
Contact details are only visible to registered journalists.